Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

The Biotechnology Industry

December 8, 2020 2

Prohost Letter #443 The Biotechnology Industry The Biotechnology Industry revolutionized the arts of life sciences with …

Why Reata Pharmaceuticals Stock is Down Today. See Also: Important News from Exelixis

December 2, 2020 0

Reata Pharmaceuticals: Why its Stock Price is Down Reata Pharmaceuticals (RETA) announced that it has priced …

Why Intellia Therapeutics’ and Moderna’s Stocks Moved South Yesterday

December 2, 2020 0

Intellia Therapeutics Intellia Therapeutics (NTLA) stock price headed south probably because some robots learned that the …

Regenxbio Announced the First Patient has been Dosed in the Phase I/II trial of RGX-111 for MPS I

December 1, 2020 0

Regenxbio Dosed First Patient with RGX-111 for MPS I Regenxbio (RGNX) has dosed the first patient …

The FDA Approved Rhythm Pharmaceuticals Product IMCIVREE™ for Genetic Obesity due to POMC, PCSK1 or LEPR Deficiency

December 1, 2020 0

Rhythm Pharmaceuticals FDA Approval of IMCIVREE™ for Genetic Obesity At the end of the trading week …

The Latest from Reata Pharmaceuticals. See Also: Prohost Picks that Reached the Moon in Today’s Trading

November 27, 2020 0

Reata Pharmaceuticals We picked Reata Pharmaceuticals (RETA) for investment after confirming that the products the Company …

The US FDA Approved Alnylam’s OXLUMO™ Injection to Lower Urinary Oxalate Levels in Pediatric and Adult Patients with PH1

November 24, 2020 0

Alnylam Announces FDA Approval of OXLUMO™ Injection for PH1 Alnylam (ALNY) announced that the US FDA …

A New COVID-19 Vaccine is Showing Successful Results. See Also: More Details About the Effective COVID-19 Vaccines

November 23, 2020 0

COVID-19 Vaccine Updates Pfizer's (PFE)/BioNTech's (BNTX) and Moderna . . . This content is for paid …

Regeneron Granted FDA Emergency Use Authorization for its COVID-19 Antibody Cocktail Therapy

November 22, 2020 0

Regeneron Pharmaceuticals Receives EUA from the FDA for REGEN-COV2 Regeneron Pharmaceuticals’ (REGN) antibody cocktail therapy casirivimab …

Pfizer and BioNTech Submitted an EUA to the FDA for their COVID-19 Vaccine, BNT162b2

November 21, 2020 0

Pfizer, BioNTech & Moderna When asked whether we heard the news about the submission of the …

Why Gilead Sciences Product Lenacapavir Deserves the FDA Granted Breakthrough Therapy Designation. See Also: Cellectis and Sanofi

November 19, 2020 0

Gilead Sciences News Results from Phase 2/3 CAPELLA trial evaluating Gilead Sciences (GILD) lenacapavir achieved the primary …

PTC Therapeutics’ Many Attractive Achievements and Approvals

November 18, 2020 0

PTC Therapeutics Approvals and Achievements PTC Therapeutics (PTCT) has achieved a lot recently. The latest is …

Inovio to Proceed with Phase 2 Trial of INO-4800 Vaccine Candidate for COVID-19

November 16, 2020 0

Inovio Announced FDA Clearance to Proceed with Trial for COVID-19 Vaccine Candidate Inovio (INO) announced the …

Moderna’s Successful COVID-19 Vaccine Results

November 16, 2020 0

Moderna Has Successful COVID-19 Vaccine Results and News Moderna’s Phase 3 study met statistical criteria with …

Moderna’s Future Growth

November 12, 2020 0

Moderna Inc COVID-19 Vaccine Candidate Moderna Inc (MRNA) announced the completion of the case accrual for …

A First in Class Antibody for a Difficult to Treat Stomach Cancer and Maybe Others

November 11, 2020 0

Five Prime Therapeutics Antibody Plus Chemotherapy for Stomach Cancer Five Prime Therapeutics (FPRX) announced positive topline results from …

About bluebird bio

November 10, 2020 0

bluebird bio bluebird bio (BLUE) financial results and business highlights for the third quarter 2020 are …

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet Success

November 9, 2020 0

Pfizer and BioNTech Good News Regarding COVID-19 Vaccine Candidate Pfizer (PFE) and BioNTech (BNTX) announced that …

CRISPR Therapeutics – Professor Emmanuelle Charpentier – Gene Editing and the Future of Humanity

November 6, 2020 0

CRISPR Therapeutics Dr. Emmanuelle Charpentier, Co-Founder CRISPR Therapeutics (CRSP) announced on October 7, 2020 that Dr. …

Why Compugen is a Favorite Biotechnology Firm

November 6, 2020 0

Compugen Compugen (CGEN) presented its third-quarter achievements and financial results. We believe the firm is on …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

The Biotechnology Industry

Why Reata Pharmaceuticals Stock is Down Today. See Also: Important News from Exelixis

Why Intellia Therapeutics’ and Moderna’s Stocks Moved South Yesterday

Regenxbio Announced the First Patient has been Dosed in the Phase I/II trial of RGX-111 for MPS I

The FDA Approved Rhythm Pharmaceuticals Product IMCIVREE™ for Genetic Obesity due to POMC, PCSK1 or LEPR Deficiency

The Latest from Reata Pharmaceuticals. See Also: Prohost Picks that Reached the Moon in Today’s Trading

The US FDA Approved Alnylam’s OXLUMO™ Injection to Lower Urinary Oxalate Levels in Pediatric and Adult Patients with PH1

A New COVID-19 Vaccine is Showing Successful Results. See Also: More Details About the Effective COVID-19 Vaccines

Regeneron Granted FDA Emergency Use Authorization for its COVID-19 Antibody Cocktail Therapy

Pfizer and BioNTech Submitted an EUA to the FDA for their COVID-19 Vaccine, BNT162b2

Why Gilead Sciences Product Lenacapavir Deserves the FDA Granted Breakthrough Therapy Designation. See Also: Cellectis and Sanofi

PTC Therapeutics’ Many Attractive Achievements and Approvals

Inovio to Proceed with Phase 2 Trial of INO-4800 Vaccine Candidate for COVID-19

Moderna’s Successful COVID-19 Vaccine Results

Moderna’s Future Growth

A First in Class Antibody for a Difficult to Treat Stomach Cancer and Maybe Others

About bluebird bio

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet Success

CRISPR Therapeutics – Professor Emmanuelle Charpentier – Gene Editing and the Future of Humanity

Why Compugen is a Favorite Biotechnology Firm